免疫调节机制在哮喘合并慢性阻塞性肺疾病中研究进展  

Research Progress of Immunomodulatory Mechanisms in Asthma Complicated with Chronic Obstructive Pulmonary Disease

作　　者：张银秀 罗维贵[2] ZHANG Yinxiu;LUO Weigui(Graduate School of Youjiang Medical University for Nationalities,Baise 533000,China;不详)

机构地区：[1]右江民族医学院,广西百色533000 [2]右江民族医学院附属医院

出　　处：《中外医学研究》2025年第6期171-175,共5页CHINESE AND FOREIGN MEDICAL RESEARCH

基　　金：北京医卫健康公益基金会医学科学研究基金资助项目(YWJKJJKYJJ-B184044)。

摘　　要：慢性阻塞性肺疾病(COPD)在中老年人群中较为多见,往往会导致患者生活质量变差且会诱发多种肺部疾病。哮喘作为全球常见的、复杂的气道异质性疾病,威胁着全球人民的安全。由于哮喘合并COPD的概率较普通人大大增加,因此,两者之间存在众多值得我们深入探讨的联系。本文就哮喘合并COPD的现状以及异常免疫应答尤其是T淋巴细胞亚群与其发生、发展关系方面做一个简要综述。Chronic obstructive pulmonary disease(COPD)is prevalent in middle-aged and older adults,often with poor quality of life and predisposing to a variety of lung diseases.Asthma,as a common and complex airway heterogeneity disease,threatens people worldwide.As the probability of asthma combined with COPD is greatly increased compared to the general population,there are numerous associations between the two that deserve to be explored in depth.In this paper,we present a brief review of the current status of asthma combined with COPD and the relationship between abnormal immune responses,especially T lymphocyte subsets,and their occurrence and development.

关 键 词：免疫调节 淋巴细胞 哮喘 慢性阻塞性肺疾病 

分 类 号：R563.9[医药卫生—呼吸系统] R562.25[医药卫生—内科学]